ZENATECH INC (ZENA) Fundamental Analysis & Valuation

NASDAQ:ZENA • CA98936T2083

Current stock price

2.17 USD
+0.06 (+2.84%)
At close:
2.18 USD
+0.01 (+0.46%)
After Hours:

This ZENA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. ZENA Profitability Analysis

1.1 Basic Checks

  • ZENA had negative earnings in the past year.
  • ZENA had a negative operating cash flow in the past year.
ZENA Yearly Net Income VS EBIT VS OCF VS FCFZENA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 -2M -4M -6M -8M -10M

1.2 Ratios

  • With a Return On Assets value of -33.63%, ZENA is not doing good in the industry: 78.18% of the companies in the same industry are doing better.
  • ZENA has a worse Return On Equity (-64.11%) than 73.09% of its industry peers.
Industry RankSector Rank
ROA -33.63%
ROE -64.11%
ROIC N/A
ROA(3y)-4.77%
ROA(5y)N/A
ROE(3y)-7.88%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ZENA Yearly ROA, ROE, ROICZENA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 -5 -10 -15 -20

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for ZENA so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ZENA Yearly Profit, Operating, Gross MarginsZENA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 -50 -100 -150 -200

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. ZENA Health Analysis

2.1 Basic Checks

  • ZENA does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for ZENA has been increased compared to 1 year ago.
  • The debt/assets ratio for ZENA has been reduced compared to a year ago.
ZENA Yearly Shares OutstandingZENA Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 5M 10M 15M 20M 25M
ZENA Yearly Total Debt VS Total AssetsZENA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 10M 20M 30M

2.2 Solvency

  • Based on the Altman-Z score of 1.55, we must say that ZENA is in the distress zone and has some risk of bankruptcy.
  • The Altman-Z score of ZENA (1.55) is comparable to the rest of the industry.
  • ZENA has a Debt/Equity ratio of 0.78. This is a neutral value indicating ZENA is somewhat dependend on debt financing.
  • ZENA has a worse Debt to Equity ratio (0.78) than 70.91% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.78
Debt/FCF N/A
Altman-Z 1.55
ROIC/WACCN/A
WACC9.89%
ZENA Yearly LT Debt VS Equity VS FCFZENA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 10M -10M 20M

2.3 Liquidity

  • ZENA has a Current Ratio of 5.42. This indicates that ZENA is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 5.42, ZENA belongs to the top of the industry, outperforming 86.18% of the companies in the same industry.
  • ZENA has a Quick Ratio of 5.42. This indicates that ZENA is financially healthy and has no problem in meeting its short term obligations.
  • ZENA has a Quick ratio of 5.42. This is amongst the best in the industry. ZENA outperforms 86.18% of its industry peers.
Industry RankSector Rank
Current Ratio 5.42
Quick Ratio 5.42
ZENA Yearly Current Assets VS Current LiabilitesZENA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 2M 4M 6M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. ZENA Growth Analysis

3.1 Past

  • The earnings per share for ZENA have decreased strongly by -1796.50% in the last year.
  • ZENA shows a strong growth in Revenue. In the last year, the Revenue has grown by 320.92%.
  • The Revenue has been decreasing by -4.94% on average over the past years.
EPS 1Y (TTM)-1796.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-743.22%
Revenue 1Y (TTM)320.92%
Revenue growth 3Y-4.94%
Revenue growth 5YN/A
Sales Q2Q%1225.1%

3.2 Future

  • Based on estimates for the next years, ZENA will show a very negative growth in Earnings Per Share. The EPS will decrease by -15.56% on average per year.
  • ZENA is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 381.18% yearly.
EPS Next Y76.78%
EPS Next 2Y-15.56%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year863.54%
Revenue Next 2Y381.18%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ZENA Yearly Revenue VS EstimatesZENA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 10M 20M 30M
ZENA Yearly EPS VS EstimatesZENA Yearly EPS VS EstimatesYearly EPS VS Estimates 2025 2026 -0.05 -0.1 -0.15 -0.2

More info and screens

Find the best growth stocksShow best growing peers

0

4. ZENA Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for ZENA. In the last year negative earnings were reported.
  • Also next year ZENA is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ZENA Price Earnings VS Forward Price EarningsZENA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ZENA Per share dataZENA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 0.4 -0.4 0.6 -0.6

4.3 Compensation for Growth

  • ZENA's earnings are expected to decrease with -15.56% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-15.56%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. ZENA Dividend Analysis

5.1 Amount

  • No dividends for ZENA!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ZENA Fundamentals: All Metrics, Ratios and Statistics

ZENATECH INC

NASDAQ:ZENA (4/10/2026, 8:00:46 PM)

After market: 2.18 +0.01 (+0.46%)

2.17

+0.06 (+2.84%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)04-06
Earnings (Next)05-12
Inst Owners3.48%
Inst Owner Change0%
Ins Owners12.14%
Ins Owner Change0%
Market Cap103.34M
Revenue(TTM)8.40M
Net Income(TTM)-26.42M
Analysts82.86
Price Target7.14 (229.03%)
Short Float %10.07%
Short Ratio1.35
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)17.1%
Min Revenue beat(2)12.1%
Max Revenue beat(2)22.09%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 17.04
P/FCF N/A
P/OCF N/A
P/B 3.47
P/tB 6.46
EV/EBITDA N/A
EPS(TTM)-0.63
EYN/A
EPS(NY)-0.17
Fwd EYN/A
FCF(TTM)-0.49
FCFYN/A
OCF(TTM)-0.39
OCFYN/A
SpS0.13
BVpS0.63
TBVpS0.34
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -33.63%
ROE -64.11%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-4.77%
ROA(5y)N/A
ROE(3y)-7.88%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.11
Health
Industry RankSector Rank
Debt/Equity 0.78
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 710.67%
Cap/Sales 74.1%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 5.42
Quick Ratio 5.42
Altman-Z 1.55
F-Score4
WACC9.89%
ROIC/WACCN/A
Cap/Depr(3y)356.04%
Cap/Depr(5y)N/A
Cap/Sales(3y)44.44%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1796.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-743.22%
EPS Next Y76.78%
EPS Next 2Y-15.56%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)320.92%
Revenue growth 3Y-4.94%
Revenue growth 5YN/A
Sales Q2Q%1225.1%
Revenue Next Year863.54%
Revenue Next 2Y381.18%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-8217.2%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-630.75%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-337.79%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-398.17%
OCF growth 3YN/A
OCF growth 5YN/A

ZENATECH INC / ZENA Fundamental Analysis FAQ

What is the fundamental rating for ZENA stock?

ChartMill assigns a fundamental rating of 2 / 10 to ZENA.


What is the valuation status for ZENA stock?

ChartMill assigns a valuation rating of 0 / 10 to ZENATECH INC (ZENA). This can be considered as Overvalued.


Can you provide the profitability details for ZENATECH INC?

ZENATECH INC (ZENA) has a profitability rating of 0 / 10.


What is the expected EPS growth for ZENATECH INC (ZENA) stock?

The Earnings per Share (EPS) of ZENATECH INC (ZENA) is expected to grow by 76.78% in the next year.